|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/08 | |
| A61K 9/19 | |||
| A61K 31/4709 |
| (11) | Patento numeris | 1945182 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 06850463.8 |
| Europos patento paraiškos padavimo data | 2006-10-13 | |
| (97) | Europos patento paraiškos paskelbimo data | 2008-07-23 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2010-07-28 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IB2006/004228 |
| Data | 2006-10-13 |
| (87) | Numeris | WO 2007/110709 |
| Data | 2007-10-04 |
| (30) | Numeris | Data | Šalis |
| 726911 P | 2005-10-14 | US |
| (72) |
DE PORRE, Peter Marie-Zoe Robert, BE
DRIES, Willy, Albert, Maria, Carlo, BE
FRANCOIS, Marc, Karel, Jozef, BE
PALMER, Peter, Albert, BE
|
| (73) |
Janssen Pharmaceutica N.V.,
Turnhoutseweg 30, 2340 Beerse,
BE
|
| (54) | FORMULATIONS OF TIPIFARNIB FOR INTRAVENOUS APPLICATION |
| FORMULATIONS OF TIPIFARNIB FOR INTRAVENOUS APPLICATION |